Log in

ETR:SBSStratec Stock Price, Forecast & News

€80.10
-2.10 (-2.55 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
€79.70
Now: €80.10
€83.90
50-Day Range
€78.90
MA: €85.24
€91.70
52-Week Range
€46.40
Now: €80.10
€93.00
Volume13,593 shs
Average Volume6,253 shs
Market Capitalization$963.23 million
P/E Ratio56.77
Dividend Yield1.02%
BetaN/A
Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates through three segments: Instrumentation, Diatron, and Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Consumables segment develops and sells scientific materials, such as nucleic acid purification; and designs and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technology. Stratec SE also develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Read More
Stratec logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.8Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.34 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-7082-79160

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$231.58 million
Cash Flow€2.77 per share
Book Value€13.11 per share

Profitability

Miscellaneous

Employees1,158
Market Cap$963.23 million
Next Earnings Date8/13/2020 (Estimated)
OptionableOptionable

Receive SBS News and Ratings via Email

Sign-up to receive the latest news and ratings for SBS and its competitors with MarketBeat's FREE daily newsletter.

Stratec (ETR:SBS) Frequently Asked Questions

How has Stratec's stock been impacted by COVID-19 (Coronavirus)?

Stratec's stock was trading at €64.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SBS shares have increased by 25.2% and is now trading at €80.10. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Stratec?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stratec in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Stratec.

When is Stratec's next earnings date?

Stratec is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Stratec.

What price target have analysts set for SBS?

4 brokerages have issued twelve-month price objectives for Stratec's stock. Their forecasts range from €69.00 to €97.00. On average, they expect Stratec's stock price to reach €85.25 in the next year. This suggests a possible upside of 6.4% from the stock's current price. View analysts' price targets for Stratec.

Has Stratec been receiving favorable news coverage?

News headlines about SBS stock have trended positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Stratec earned a coverage optimism score of 2.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutStratec.

Who are some of Stratec's key competitors?

What other stocks do shareholders of Stratec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Co. (USD) (CHC), Bio-Rad Laboratories (BIO), Berkshire Hills Bancorp (BHLB), ASGN (ASGN), Apptio (APTI) and Anadarko Petroleum (APC).

Who are Stratec's key executives?

Stratec's management team includes the following people:
  • Mr. Marcus Wolfinger, Chairman of Board of Management & CEO (Age 52)
  • Dr. Robert Siegle, Director of Fin. & HR and Member of Board of Management (Age 52)
  • Dr. Claus Vielsack, Director of Product Devel. & Member of Board of Management (Age 52)
  • Mr. Hermann Leistner, Founder & Advisor (Age 73)
  • Sandra Eberle, Head of Investor Relations

What is Stratec's stock symbol?

Stratec trades on the ETR under the ticker symbol "SBS."

What is Stratec's stock price today?

One share of SBS stock can currently be purchased for approximately €80.10.

How big of a company is Stratec?

Stratec has a market capitalization of $963.23 million and generates $231.58 million in revenue each year. Stratec employs 1,158 workers across the globe.

What is Stratec's official website?

The official website for Stratec is www.stratec.com.

How can I contact Stratec?

Stratec's mailing address is Gewerbestr. 37, BIRKENFELD, 75217, Germany. The company can be reached via phone at +49-7082-79160.

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.